Colon cancer: Curcumin activates tumor suppressive signaling pathway

June 6, 2023
LMU researchers have identified a signaling pathway via which curcumin can suppress the metastasis of colorectal cancer cells.

Colorectal cancer ranks among the most prevalent cancer types worldwide. Mutations commonly deactivate a vital defense mechanism within cells, known as the tumor suppressor gene p53, in more than half of the cases. The gene's resultant product, a transcription factor, triggers the emergence of a microRNA molecule called miR-34, which plays a pivotal part in suppressing tumors. Under the guidance of Heiko Hermeking, a Professor of Experimental and Molecular Pathology at LMU, a team has now proven that curcumin, an inherent compound found in the spice turmeric, can revive this repressed protective mechanism. Curcumin achieves this by stimulating a distinct, alternative signaling pathway that prompts the expression of miR-34, as demonstrated in cell cultures and a mouse model.

By utilizing genetically modified human colorectal cancer cell lines, the researchers have now illustrated that curcumin elevates the production of reactive oxygen species (ROS) within tumor cells. These ROS activate a signaling pathway that triggers the generation of miR-34 through the involvement of the transcription factor NRF2. Consequently, premature aging and programmed cell death are induced in the tumor cells.

A crucial aspect of the findings is that these effects occur irrespective of p53, which is frequently inactivated in most tumor types and challenging to restore in all tumor cells.

LMU release on Newswise